ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Our evaluation and opinions of the EPI-321 clinical trial design and potential based on the pre-clinical data"
Episode Synopsis
"But did you bleed him? - Aesculapius says that bleeding is not a cure. It is only a way of proving that you are a physician at the expense of your patient." Finally, we discuss the EPI-321 epigenetic editing phase I/II clinical trial design and its potential for answering key questions necessary for going to phase III and for providing benefit to participants and patients.
In God we trust